Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Federico Garrido
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Genes & Molecular Sequences
Physiology
Anatomy
Disorders
Living Beings
Sign-in to see full Profile
Network (preview)
93
Ruiz-Cabello, Francisco
52
Cabrera, Teresa
30
Algarra, Ignacio
23
Concha, Angel
20
Collado, Antonia
16
Maleno, Isabel
15
Garcia-Lora, Angel
14
Aptsiauri, Natalia
13
Gaforio, José Juan
13
Oliva, Maria
12
Real, Luis Miguel
12
Serrano, A
12
Jimenez, Pilar
11
López-Nevot, Miguel
10
Lopez-Nevot, Miguel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Federico Garrido (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Garrido Cristina; Algarra Ignacio; Maleno Isabel; Stefanski Julia; Collado Antonia; Garrido Federico; Garcia-Lora Angel M
Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.
Cancer immunology, immunotherapy : CII 2010;59(1):13-26.
-
2009: Bernal Mónica; Garrido Pilar; Jiménez Pilar; Carretero Rafael; Almagro Manuel; López Pilar; Navarro Pilar; Garrido Federico; Ruiz-Cabello Francisco
Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.
Human immunology 2009;70(10):854-7.
-
2009: Mendez Rosa; Aptsiauri Natalia; Del Campo Ana; Maleno Isabel; Cabrera Teresa; Ruiz-Cabello Francisco; Garrido Federico; Garcia-Lora Angel
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.
Cancer immunology, immunotherapy : CII 2009;58(9):1507-15.
-
2009: del Campo A B; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
Scandinavian journal of immunology 2009;70(2):125-35.
-
2009: Romero José María; Sáenz-López Pablo; Cózar José Manuel; Carretero Rafael; Canton Julia; Vazquez Fernando; Concha Angel; Tallada Miguel; Garrido Federico; Ruiz-Cabello Francisco
A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Human immunology 2009;70(1):60-4.
-
2008: Aptsiauri Natalia; Carretero Rafael; Garcia-Lora Angel; Real Luis M; Cabrera Teresa; Garrido Federico
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.
Cancer immunology, immunotherapy : CII 2008;57(11):1727-33.
-
2008: Carretero Rafael; Romero José M; Ruiz-Cabello Francisco; Maleno Isabel; Rodriguez Felix; Camacho Francisco M; Real Luis M; Garrido Federico; Cabrera Teresa
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.
Immunogenetics 2008;60(8):439-47.
-
2008: Méndez Rosa; Rodríguez Teresa; Del Campo Ana; Monge Eva; Maleno Isabel; Aptsiauri Natalia; Jiménez Pilar; Pedrinaci Susana; Pawelec Graham; Ruiz-Cabello Francisco; Garrido Federico
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Cancer immunology, immunotherapy : CII 2008;57(5):719-29.
-
2008: Sáenz-López Pablo; Carretero Rafael; Cózar José Manuel; Romero José Maria; Canton Julia; Vilchez José Ramón; Tallada Miguel; Garrido Federico; Ruiz-Cabello Francisco
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
BMC cancer 2008;8():382.
-
2008: Cozar Jose Manuel; Aptsiauri Natalia; Tallada Miguel; Garrido Federico; Ruiz-Cabello Francisco
Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report.
Journal of medical case reports 2008;2():111.
-
2008: Jiménez-Medina Eva; Berruguilla Enrique; Romero Irene; Algarra Ignacio; Collado Antonia; Garrido Federico; Garcia-Lora Angel
The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis.
BMC cancer 2008;8():78.
-
2007: Paco Laura; Garcia-Lora Angel Miguel; Casares Carlos; Cabrera Carmen; Algarra Ignacio; Collado Antonia; Maleno Isabel; Garrido Federico; Lopez-Nevot Miguel Angel
Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.
International journal of cancer. Journal international du cancer 2007;121(9):2023-30.
-
2007: Cozar Jose M; Romero Jose M; Aptsiauri Natalia; Vazquez Fernando; Vilchez Jose R; Tallada Miguel; Garrido Federico; Ruiz-Cabello Francisco
High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Human immunology 2007;68(8):698-704.
-
2007: Aptsiauri Natalia; Cabrera Teresa; Pawelec Graham; Gouttefangeas Cécile; Derhovanessian Evelyna; Garrido Federico; Garcia-Lora Angel
International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Cancer immunology, immunotherapy : CII 2007;56(8):1311-22.
-
2007: Cabrera Teresa; Lara Ester; Romero José M; Maleno Isabel; Real Luis M; Ruiz-Cabello Francisco; Valero Pedro; Camacho Francisco M; Garrido Federico
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
Cancer immunology, immunotherapy : CII 2007;56(5):709-17.
-
2007: Cabrera T; Maleno I; Collado A; Lopez Nevot M A; Tait B D; Garrido F
Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.
Tissue antigens 2007;69 Suppl 1():264-8.
-
2007: Rodriguez T; Aptsiauri N; Méndez R; Jimenez P; Ruiz-Cabello F; Garrido F
Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
Tissue antigens 2007;69 Suppl 1():259-63.
-
2007: Middleton D; Vilchez J R; Cabrera T; Meenagh A; Williams F; Halfpenny I; Maleno I; Ruiz-Cabello F; Lopez-Nevot M A; Garrido F
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.
Tissue antigens 2007;69(3):220-6.
-
2007: Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Immunogenetics 2007;59(2):123-33.
-
2007: Méndez Rosa; Ruiz-Cabello Francisco; Rodríguez Teresa; Del Campo Ana; Paschen Annette; Schadendorf Dirk; Garrido Federico
Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
Cancer immunology, immunotherapy : CII 2007;56(1):88-94.
-
2007: Aptsiauri Natalia; Cabrera Teresa; Mendez Rosa; Garcia-Lora Angel; Ruiz-Cabello Francisco; Garrido Federico
Role of altered expression of HLA class I molecules in cancer progression.
Advances in experimental medicine and biology 2007;601():123-31.
-
2007: Rodríguez Teresa; Méndez Rosa; Del Campo Ana; Jiménez Pilar; Aptsiauri Natalia; Garrido Federico; Ruiz-Cabello Francisco
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
BMC cancer 2007;7():34.
-
2007: Aptsiauri Natalia; Cabrera Teresa; Garcia-Lora Angel; Lopez-Nevot Miguel Angel; Ruiz-Cabello Francisco; Garrido Federico
MHC class I antigens and immune surveillance in transformed cells.
International review of cytology 2007;256():139-89.
-
2006: Romero J M; Aptsiauri N; Vazquez F; Cozar J M; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Tissue antigens 2006;68(4):303-10.
-
2006: Maleno Isabel; Romero Jose Maria; Cabrera Teresa; Paco Laura; Aptsiauri Natalia; Cozar Jose Manuel; Tallada Miguel; López-Nevot Miguel Angel; Garrido Federico
LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Immunogenetics 2006;58(7):503-10.
-
2006: Jiménez-Medina Eva; Garcia-Lora Angel; Paco Laura; Algarra Ignacio; Collado Antonia; Garrido Federico
A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation.
BMC cancer 2006;6():119.
-
2005: Cózar Jose Manuel; Canton Julia; Tallada Miguel; Concha Angel; Cabrera Teresa; Garrido Federico; Ruiz-Cabello Osuna Francisco
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cancer immunology, immunotherapy : CII 2005;54(9):858-66.
-
2005: Alvarado-Guerri Rocío; Cabrera Carmen M; Garrido Federico; López-Nevot Miguel Angel
TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population.
Human immunology 2005;66(8):921-30.
-
2005: Jiménez Eva; Garcia-Lora Angel; Martinez Marisol; Garrido Federico
Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells.
Cancer immunology, immunotherapy : CII 2005;54(4):395-9.
-
2005: Rodriguez Teresa; Méndez Rosa; Roberts Chrissy H; Ruiz-Cabello Francisco; Dodi I Anthony; López Nevot Miguel Angel; Paco Laura; Maleno Isabel; Marsh Steven G E; Pawelec Graham; Garrido Federico
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer immunology, immunotherapy : CII 2005;54(2):141-8.
-
2005: Romero Jose María; Jiménez Pilar; Cabrera Teresa; Cózar José Manuel; Pedrinaci Susana; Tallada Miguel; Garrido Federico; Ruiz-Cabello Francisco
Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
International journal of cancer. Journal international du cancer 2005;113(4):605-10.
-
2005: Cabrera Carmen M; López-Nevot Miguel-Angel; Jiménez Pilar; Garrido Federico
Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors.
International journal of cancer. Journal international du cancer 2005;113(4):611-8.
-
2004: Algarra Ignacio; García-Lora Angel; Cabrera Teresa; Ruiz-Cabello Francisco; Garrido Federico
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Cancer immunology, immunotherapy : CII 2004;53(10):904-10.
-
2004: Maleno Isabel; Cabrera Carmen Maria; Cabrera Teresa; Paco Laura; López-Nevot Miguel Angel; Collado Antonia; Ferrón Antonio; Garrido Federico
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Immunogenetics 2004;56(4):244-53.
-
2004: Tormos Carmen; Javier Chaves F; Garcia Maria José; Garrido Federico; Jover Ramiro; O'Connor José Enrique; Iradi Antonio; Oltra Ana; Oliva Maria R; Sáez Guillermo T
Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.
Cancer letters 2004;208(1):103-13.
-
2004: Cabrera C M; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Tissue antigens 2004;63(5):446-52.
-
2004: Maleno Isabel; Lopez Nevot Miguel Angel; Seliger Barbara; Garrido Federico
Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
International journal of cancer. Journal international du cancer 2004;109(4):636-8.
-
2003: Cabrera Teresa; Maleno Isabel; Lopez-Nevot Miguel Angel; Redondo Maximino; Fernandez Maria Angustias; Collado Antonia; Garrido Federico
High frequency of HLA-B44 allelic losses in human solid tumors.
Human immunology 2003;64(10):941-50.
-
2003: Cabrera T; Pedrajas G; Cozar J M; Garrido A; Vicente J; Tallada M; Garrido F
HLA class I expression in bladder carcinomas.
Tissue antigens 2003;62(4):324-7.
-
2003: Garcia-Lora Angel; Martinez Marisol; Algarra Ignacio; Gaforio Jose Juan; Garrido Federico
MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
International journal of cancer. Journal international du cancer 2003;106(4):521-7.
-
2003: García-Lora A; Algarra I; Collado A; Garrido F
Tumour immunology, vaccination and escape strategies.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2003;30(3):177-83.
-
2003: Garcia-Lora Angel; Algarra Ignacio; Garrido Federico
MHC class I antigens, immune surveillance, and tumor immune escape.
Journal of cellular physiology 2003;195(3):346-55.
-
2003: Cabrera C M; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Tissue antigens 2003;61(3):211-9.
-
2003: Paschen Annette; Méndez Rosa María; Jimenez Pilar; Sucker Antje; Ruiz-Cabello Francisco; Song Mingxia; Garrido Federico; Schadendorf Dirk
Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
International journal of cancer. Journal international du cancer 2003;103(6):759-67.
-
2003: Marín Rosario; Ruiz-Cabello Francisco; Pedrinaci Susana; Méndez Rosa; Jiménez Pilar; Geraghty Daniel E; Garrido Federico
Analysis of HLA-E expression in human tumors.
Immunogenetics 2003;54(11):767-75.
-
2003: García-Lora Angel; Martinez Marisol; Pedrinaci Susana; Garrido Federico
Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.
Cancer immunology, immunotherapy : CII 2003;52(1):59-64.
-
2003: Cabrera Teresa; López-Nevot Miguel Angel; Gaforio Jose Juan; Ruiz-Cabello Francisco; Garrido Federico
Analysis of HLA expression in human tumor tissues.
Cancer immunology, immunotherapy : CII 2003;52(1):1-9.
-
2002: Maleno Isabel; López-Nevot Miguel Angel; Cabrera Teresa; Salinero José; Garrido Federico
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Cancer immunology, immunotherapy : CII 2002;51(7):389-96.
-
2002: Ruiz-Cabello Francisco; Cabrera Teresa; Lopez-Nevot Miguel-Angel; Garrido Federico
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.
Seminars in cancer biology 2002;12(1):15-24.
-
2001: Serrano A; Tanzarella S; Lionello I; Mendez R; Traversari C; Ruiz-Cabello F; Garrido F
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment.
International journal of cancer. Journal international du cancer 2001;94(2):243-51.
-
2001: Jiménez P; Cabrera T; Méndez R; Esparza C; Cozar J M; Tallada M; López-Nevot M A; Ruiz-Cabello F; Garrido F
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line.
Immunogenetics 2001;53(7):606-10.
-
2001: Oliva M R; Iradi A; Garrido F; Ramos M; Oltra A M; Muñiz P; Sáez G T
Oxidative stress induces the expression of the major histocompatibility complex in murine tumor cells.
Free radical research 2001;35(2):119-28.
-
2001: Mendez R; Serrano A; Jäger E; Maleno I; Ruiz-Cabello F; Knuth A; Garrido F
Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy.
Tissue antigens 2001;57(6):508-19.
-
2001: García-Lora A; Pedrinaci S; Garrido F
Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line.
Cancer immunology, immunotherapy : CII 2001;50(4):191-8.
-
2001: Ramal L M; de Pablo R; Guadix M J; Sánchez J; Garrido A; Garrido F; Jiménez-Alonso J; López-Nevot M A
HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain.
Tissue antigens 2001;57(2):138-43.
-
2001: Real L M; Jimenez P; Kirkin A; Serrano A; García A; Cantón J; Zeuthen J; Garrido F; Ruiz-Cabello F
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.
Cancer immunology, immunotherapy : CII 2001;49(11):621-8.
-
2001: Garcia-Lora A; Algarra I; Gaforio J J; Ruiz-Cabello F; Garrido F
Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
International journal of cancer. Journal international du cancer 2001;91(1):109-19.
-
2001: Garrido F; Algarra I
MHC antigens and tumor escape from immune surveillance.
Advances in cancer research 2001;83():117-58.
-
2000: Ramal L M; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot M A; Garrido F
Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Human immunology 2000;61(10):1001-12.
-
2000: Serrano A; Brady C S; Jimenez P; Duggan-Keen M F; Mendez R; Stern P; Garrido F; Ruiz-Cabello F
A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells.
Immunogenetics 2000;51(12):1047-52.
-
2000: Ramal L M; Feenstra M; van der Zwan A W; Collado A; Lopez-Nevot M A; Tilanus M; Garrido F
Criteria to define HLA haplotype loss in human solid tumors.
Tissue antigens 2000;55(5):443-8.
-
2000: Brady C S; Bartholomew J S; Burt D J; Duggan-Keen M F; Glenville S; Telford N; Little A M; Davidson J A; Jimenez P; Ruiz-Cabello F; Garrido F; Stern P L
Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Tissue antigens 2000;55(5):401-11.
-
2000: Cabrera T; Salinero J; Fernandez M A; Garrido A; Esquivias J; Garrido F
High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Human immunology 2000;61(5):499-506.
-
2000: Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real L M; García A; Serrano A; Garrido F; Ruiz-Cabello F
Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Cancer immunology, immunotherapy : CII 2000;48(12):684-90.
-
2000: Algarra I; Cabrera T; Garrido F
The HLA crossroad in tumor immunology.
Human immunology 2000;61(1):65-73.
-
2000: Fernández M A; Ruiz-Cabello F; Oliva M R; Cabrera T; Jimenez P; López Nevot M A; Garrido F
Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
International journal of clinical & laboratory research 2000;30(2):87-92.
-
1999: Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real L M; García A; Ruiz-Cabello F; Garrido F
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
International journal of cancer. Journal international du cancer 1999;83(1):91-7.
-
1999: Real L M; Cabrera T; Canton J; Oliva R; Ruiz-Cabello F; Garrido F
Looking for HLA-G expression in human tumours.
Journal of reproductive immunology 1999;43(2):263-73.
-
1999: Pérez B; Benitez R; Fernández M A; Oliva M R; Soto J L; Serrano S; López Nevot M A; Garrido F
A new beta 2 microglobulin mutation found in a melanoma tumor cell line.
Tissue antigens 1999;53(6):569-72.
-
1999: Real L M; Cabrera T; Collado A; Jimenez P; Garcia A; Ruiz-Cabello F; Garrido F
Expression of HLA G in human tumors is not a frequent event.
International journal of cancer. Journal international du cancer 1999;81(4):512-8.
-
1999: Algarra I; Gaforio J J; Cabrera T; Collado A; Garrido F
The biological consequences of altered MHC class I expression in tumours.
Journal of biological regulators and homeostatic agents 1999;13(2):90-6.
-
1999: Algarra I; Collado A; Garcia Lora A; Garrido F
Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.
Journal of experimental & clinical cancer research : CR 1999;18(1):39-46.
-
1999: García A; Serrano A; Abril E; Jimenez P; Real L M; Cantón J; Garrido F; Ruiz-Cabello F
Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression.
Experimental hematology 1999;27(2):353-64.
-
1999: Pedrinaci S; Algarra I; Garcia Lora A; Gaforio J J; Perez M; Garrido F
Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.
International journal of clinical & laboratory research 1999;29(4):166-73.
-
1999: Pedrinaci S; Algarra I; Garrido F
Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line.
International journal of clinical & laboratory research 1999;29(4):135-40.
-
1998: Benitez R; Godelaine D; Lopez-Nevot M A; Brasseur F; Jiménez P; Marchand M; Oliva M R; van Baren N; Cabrera T; Andry G; Landry C; Ruiz-Cabello F; Boon T; Garrido F
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Tissue antigens 1998;52(6):520-9.
-
1998: Abril E; Real L M; Serrano A; Jimenez P; García A; Canton J; Trigo I; Garrido F; Ruiz-Cabello F
Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.
Cancer immunology, immunotherapy : CII 1998;47(2):113-20.
-
1998: Jiménez P; Cantón J; Concha A; Torres L M; Abril E; Real L M; García A; Garrido F; Ruiz-Cabello F
Microsatellite instability in cervical intraepithelial neoplasia.
Journal of experimental & clinical cancer research : CR 1998;17(3):361-6.
-
1998: Cabrera T; Collado A; Fernandez M A; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Tissue antigens 1998;52(2):114-23.
-
1998: Real L M; Jimenez P; Cantón J; Kirkin A; García A; Abril E; Zeuthen J; Ruiz-Cabello F; Garrido F
In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele.
International journal of cancer. Journal international du cancer 1998;75(2):317-23.
-
1998: Algarra I; Perez M; Serrano M J; Garrido F; Gaforio J J
c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma.
Invasion & metastasis 1998;18(5-6):261-70.
-
1997: Algarra I; Collado A; Garrido F
Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Journal of experimental & clinical cancer research : CR 1997;16(4):373-80.
-
1997: Garrido F; Ruiz-Cabello F; Cabrera T; Pérez-Villar J J; López-Botet M; Duggan-Keen M; Stern P L
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
Immunology today 1997;18(2):89-95.
-
1997: Algarra I; Collado A; Garrido F
Altered MHC class I antigens in tumors.
International journal of clinical & laboratory research 1997;27(2):95-102.
-
1996: Esteban F; Redondo M; Delgado M; Garrido F; Ruiz-Cabello F
MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.
British journal of cancer 1996;74(11):1801-4.
-
1996: Serrano A; García A; Abril E; Garrido F; Ruiz-Cabello F
Methylated CpG points identified within MAGE-1 promoter are involved in gene repression.
International journal of cancer. Journal international du cancer 1996;68(4):464-70.
-
1996: Cabrera T; Angustias Fernandez M; Sierra A; Garrido A; Herruzo A; Escobedo A; Fabra A; Garrido F
High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Human immunology 1996;50(2):127-34.
-
1996: Abril E; Mendez R E; García A; Serrano A; Cabrera T; Garrido F; Ruiz-Cabello F
Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
Tissue antigens 1996;47(5):391-8.
-
1996: Torres M J; Ruiz-Cabello F; Skoudy A; Berrozpe G; Jimenez P; Serrano A; Real F X; Garrido F
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.
Tissue antigens 1996;47(5):372-81.
-
1996: Algarra I; González A; Pérez M; Gaforio J J; Garrido F
Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours.
Clinical and experimental immunology 1996;103(3):499-505.
-
1995: Serrano A; Garcia A; Abril E; Garrido F; Ruiz-Cabello F
Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).
Immunobiology 1995;194(4-5):449-56.
-
1995: Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(4):299-310.
-
1995: Cabrera T; Ruiz-Cabello F; Garrido F
Biological implications of HLA-DR expression in tumours.
Scandinavian journal of immunology 1995;41(4):398-406.
-
1995: Garrido F; Cabrera T; Lopez-Nevot M A; Ruiz-Cabello F
HLA class I antigens in human tumors.
Advances in cancer research 1995;67():155-95.
-
1994: Algarra I; Pérez M; Gaforio J J; Gasca F; Garrido F
In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones.
Clinical & experimental metastasis 1994;12(1):31-6.
-
1993: Algarra I; Pérez M; Höglund P; Gaforio J J; Ljunggren H G; Garrido F
Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue.
International journal of cancer. Journal international du cancer 1993;54(3):518-23.
-
1993: Torres L M; Cabrera T; Concha A; Oliva M R; Ruiz-Cabello F; Garrido F
HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Tissue antigens 1993;41(2):65-71.
-
1992: Prados J; Fernández J E; Garrido F; Alvarez L; Hidalgo R; Muros M A; Aránega A
Expression of alpha-tropomyosin during cardiac development in the chick embryo.
The Anatomical record 1992;234(3):301-9.
-
1992: Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva M R; Ruiz-Cabello F; Serrano S; Garrido F
HLA molecules in basal cell carcinoma of the skin.
Immunobiology 1992;185(5):440-52.
-
1992: Mialdea M J; Martin J; Gaforio J J; Algarra I; Pérez M; Gonzalez A; Ljunggren H G; Garrido F
Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
International journal of cancer. Journal international du cancer 1992;52(1):153-8.
-
1991: Gaforio J J; Pérez M; Algarra I; Mialdea M J; Ljunggren H G; Garrido F
Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
International journal of cancer. Journal international du cancer 1991;49(6):906-10.
-
1991: Collado A; de Andres A; Cañadas E; Ruiz-Cabello F; Gomez O; Pedrinaci S; Garrido F
Characterization of CD44 antigen during lymphoid ontogeny.
Immunobiology 1991;183(1-2):1-11.
-
1991: Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Cancer research 1991;51(18):4948-54.
-
1991: Fernández J E; Concha A; Aránega A; Ruiz-Cabello F; Cabrera T; Garrido F
HLA class I and II expression in rhabdomyosarcomas.
Immunobiology 1991;182(5):440-8.
-
1991: Cabrera T; Concha A; Ruiz-Cabello F; Garrido F
Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
Scandinavian journal of immunology 1991;34(2):147-52.
-
1991: Ruiz-Cabello F; Klein E; Garrido F
MHC antigens on human tumors.
Immunology letters 1991;29(3):181-9.
-
1991: Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva M R; Garrido F
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Cancer research 1991;51(9):2463-8.
-
1991: Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Seminars in cancer biology 1991;2(1):47-54.
-
1991: Garrido F; Ruiz-Cabello F
MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Seminars in cancer biology 1991;2(1):3-10.
-
1991: Algarra I; Gaforio J J; Garrido A; Mialdea M J; Pérez M; Garrido F
Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():73-81.
-
1991: Concha A; Cabrera T; Ruiz-Cabello F; Garrido F
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():146-54.
-
1991: Ruiz-Cabello F; Perez-Ayala M; Gomez O; Redondo M; Concha A; Cabrera T; Garrido F
Molecular analysis of MHC-class-I alterations in human tumor cell lines.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():123-30.
-
1991: Martín J; Almeida D; Mialdea M J; Rodriguez M; Mataran L; Garrido F
DNA-RFLP analysis and genotyping of HLA-DR alleles in the south of Spain.
Experimental and clinical immunogenetics 1991;8(2):119-20.
-
1990: Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
British journal of cancer 1990;62(6):1047-51.
-
1990: Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens]
Acta otorrinolaringológica española 1990;41(6):359-68.
-
1990: Esteban F; Ruiz-Cabello F; Concha A; Perez Ayala M; Delgado M; Garrido F
Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx.
Cancer 1990;66(7):1493-8.
-
1990: Oliva M R; Cabrera T; Esquivias J; Perez-Ayala M; Redondo M; Ruiz-Cabello F; Garrido F
K-ras mutations (codon 12) are not involved in down-regulation of MHC class-I genes in colon carcinomas.
International journal of cancer. Journal international du cancer 1990;46(3):426-31.
-
1990: Esteban F; Concha A; Ruiz-Cabello F; Garrido F
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens]
Acta otorrinolaringológica española 1990;41(5):297-303.
-
1990: Pérez M; Algarra I; Ljunggren H G; Caballero A; Mialdea M J; Gaforio J J; Klein G; Kärre K; Garrido F
A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
International journal of cancer. Journal international du cancer 1990;46(2):258-61.
-
1990: Esteban F; Ruiz-Cabello F; Concha A; Pérez-Ayala M; Sánchez-Rozas J A; Garrido F
HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
Clinical & experimental metastasis 1990;8(4):319-28.
-
1990: Pérez-Ayala M; Ruiz-Cabello F; Esteban F; Concha A; Redondo M; Oliva M R; Cabrera T; Garrido F
Presence of HPV 16 sequences in laryngeal carcinomas.
International journal of cancer. Journal international du cancer 1990;46(1):8-11.
-
1990: Gutierrez J; Ruiz-Cabello F; López Nevot M A; Cabrera T; Esquivias J; Garrido F
Class II HLA antigen expression in familial polyposis coli is related to the degree of dysplasia.
Immunobiology 1990;180(2-3):138-48.
-
1990: Lopez Nevot M A; Cardona L; Doblaré E; Muñoz C; Ruiz-Cabello F; Garrido F
The monoclonal antibody GRC1 produced against human cornea recognizes a common determinant of collagen.
Investigative ophthalmology & visual science 1990;31(2):290-3.
-
1990: Pedrinaci S; Ruiz-Cabello F; Gomez O; Collado A; Garrido F
Protein kinase C-mediated regulation of the expression of CD14 and CD11/CD18 in U937 cells.
International journal of cancer. Journal international du cancer 1990;45(2):294-8.
-
1989: Algarra I; Ohlén C; Perez M; Ljunggren H G; Klein G; Garrido F; Kärre K
NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.
International journal of cancer. Journal international du cancer 1989;44(4):675-80.
-
1989: Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva M R; Ruiz-Cabello F; Garrido F
MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Journal of immunogenetics 1989;16(4-5):413-23.
-
1989: Caballero A; Garrido A; Algarra I; Perez M; Garrido F
Generation of syngeneic anti-tumour double negative cells (CD4- CD8-), with cytotoxic activity against clones of different MHC class I expression.
Journal of immunogenetics 1989;16(4-5):321-8.
-
1989: Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
International journal of cancer. Journal international du cancer 1989;43(3):436-42.
-
1989: López-Nevot M A; Esteban F; Ferrón A; Gutiérrez J; Oliva M R; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
British journal of cancer 1989;59(2):221-6.
-
1989: Pedrinaci S; Huelin C; Patarroyo M; Ruiz-Cabello F; Garrido F
Studies on CD11a and CD18 molecules with two new monoclonal antibodies: differential myelomonocytic antigen expression of PMA treated HL60 and U937 cell lines.
Hybridoma 1989;8(1):13-23.
-
1989: Ruiz-Cabello F; Huelin C; Pedrinaci S; Lopez Nevot M A; Garrido F
Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity.
Hybridoma 1989;8(1):1-11.
-
1989: Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado M D; Fernández-Cruz E; Garrido F
H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Experimental and clinical immunogenetics 1989;6(3):204-18.
-
1988: Huelin C; Gonzalez M; Pedrinaci S; de la Higuera B; Piris M A; San Miguel J; Ruiz-Cabello F; Garrido F
Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: the CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders.
British journal of haematology 1988;69(2):173-9.
-
1988: López-Nevot M A; Garcia E; Romero C; Oliva M R; Serrano S; Garrido F
Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
Experimental and clinical immunogenetics 1988;5(4):203-12.
-
1987: Cañadas E; de Andres M; de la Higuera B; Muñoz F J; Pedrinaci S; Ruiz-Cabello F; Garrido F
Study of the monoclonal antibodies against blood group B and A + B (group 2) of the First International Workshop. Pattern of reaction with colon carcinomas.
Revue française de transfusion et immuno-hématologie 1987;30(5):609-11.
-
1987: de Andres M; Cañadas E; Muñoz F J; de la Higuera B; Pedrinaci S; Ruiz-Cabello F; Garrido F
Study of the monoclonal antibodies against blood group A (group N. 1) of the First International Workshop. Pattern of reaction with normal colon mucosa and colon carcinomas.
Revue française de transfusion et immuno-hématologie 1987;30(5):485-8.
-
1987: Ruiz-Cabello F; de la Higuera B; López Nevot M A; Huelin C; Conejo J M; Garrido F
A monoclonal antibody, GR7A4, reacting with the T10 antigen.
Hybridoma 1987;6(3):275-84.
-
1987: Gutierrez J; López-Nevot M A; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Experimental and clinical immunogenetics 1987;4(3):144-52.
-
1987: Ruiz-Cabello F; López Nevot M A; Garrido A; Garrido F
A study of GRM1 monoclonal antibody that reacts with natural killer cells and granulocytes.
Natural immunity and cell growth regulation 1987;6(2):99-108.
-
1987: de Andrés M; Ruiz-Cabello F; López Nevot M A; Huelin C; Conejo J M; Cabrera A; Garrido F
[Presentation of 2 new anti-blood group A monoclonal antibodies: study and characterization]
Sangre 1987;32(1):1-5.
-
1986: Delgado C; Garrido A; Pérez M; Garrido M L; Algarra I; Garrido F
Characterization of the syngeneic anti-tumour response against the GR9 tumour with the production of isoantisera and monoclonal antibodies.
Journal of immunogenetics 1986;13(2-3):169-77.
-
1986: Garrido M L; Pérez M; Delgado C; Rojano J; Algarra I; Garrido A; Garrido F
Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour, GR9.
Journal of immunogenetics 1986;13(2-3):159-67.
-
1986: Lopez Nevot M A; Garcia E; Pareja E; Bonal F J; Martin J; Ruiz-Cabello F; Serrano S; Garrido F
Differential expression of HLA class I and II antigens in primary and metastatic melanomas.
Journal of immunogenetics 1986;13(2-3):219-27.
-
1986: Pérez M; Cabrera T; Lopez Nevot M A; Gomez M; Peran F; Ruiz-Cabello F; Garrido F
Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma.
Journal of immunogenetics 1986;13(2-3):247-53.
-
1986: Bonal F J; Pareja E; Martin J; Romero C; Garrido F
Repression of class I H-2K, H-2D antigens on GR9 methylcholanthrene-induced tumour cell clones is related to the level of DNA methylation.
Journal of immunogenetics 1986;13(2-3):179-86.
-
1986: Cabrera T; Ruiz-Cabello F; Lopez M A; de la Higuera B; Sanchez M; Garrido F
Characterization of monoclonal antibodies directed against HLA class II molecules.
Hybridoma 1986;5(3):191-7.
-
1986: López Nevot M A; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
[A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia]
Sangre 1986;31(6):751-8.
-
1986: Garrido A; Pérez M; Delgado C; Garrido M L; Rojano J; Algarra I; Garrido F
Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
Experimental and clinical immunogenetics 1986;3(2):98-110.
-
1985: Gómez Morales M; De Andrés M A; Garrido M L; Delgado C; Cabrera A; Garrido F
[Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies]
Sangre 1985;30(3):348-54.
-
1985: Pareja E; Bonal F J; Paule P; Salvatierra D; Garrido F
HLA antigens in brucellosis.
Experimental and clinical immunogenetics 1985;2(1):1-3.
-
1985: Gomez-Morales M; Ruiz-Cabello F; López M A; Collado A; Cabrera T; San Miguel J; Garrido F
A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias.
Hybridoma 1985;4(4):369-78.
-
1985: Ruiz-Cabello F; González M; López M A; Cabrera A; San Miguel J; Garrido F
[A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens]
Sangre 1985;30(2):190-6.
Sign-in to see more
